JPH0259816B2 - - Google Patents
Info
- Publication number
- JPH0259816B2 JPH0259816B2 JP14544683A JP14544683A JPH0259816B2 JP H0259816 B2 JPH0259816 B2 JP H0259816B2 JP 14544683 A JP14544683 A JP 14544683A JP 14544683 A JP14544683 A JP 14544683A JP H0259816 B2 JPH0259816 B2 JP H0259816B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- examples
- compound
- lower alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 5
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- -1 methoxy, ethoxy, propoxy, isopropoxy, butoxy, t-butoxy, pentyloxy Chemical group 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- SWNROPPWBFHVCS-UHFFFAOYSA-N 1,4,5,8-tetramethoxynaphthalene Chemical compound C1=CC(OC)=C2C(OC)=CC=C(OC)C2=C1OC SWNROPPWBFHVCS-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14544683A JPS6036436A (ja) | 1983-08-08 | 1983-08-08 | アルコキシナフタレン誘導体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14544683A JPS6036436A (ja) | 1983-08-08 | 1983-08-08 | アルコキシナフタレン誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6036436A JPS6036436A (ja) | 1985-02-25 |
JPH0259816B2 true JPH0259816B2 (enrdf_load_stackoverflow) | 1990-12-13 |
Family
ID=15385410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14544683A Granted JPS6036436A (ja) | 1983-08-08 | 1983-08-08 | アルコキシナフタレン誘導体 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6036436A (enrdf_load_stackoverflow) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5026759A (en) * | 1985-05-08 | 1991-06-25 | Du Pont Merck Pharmaceutical | 2-substituted-1-naphthols as 5-lipoxygenase inhibitors |
CN103833539A (zh) * | 2014-01-23 | 2014-06-04 | 上海甘田光学材料有限公司 | 一种芳基萘甲酮衍生物及其制备方法 |
-
1983
- 1983-08-08 JP JP14544683A patent/JPS6036436A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6036436A (ja) | 1985-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chapleo et al. | . alpha.-Adrenoceptor reagents. 2. Effects of modification of the 1, 4-benzodioxan ring system on. alpha.-adrenoreceptor activity | |
JPH0625068A (ja) | 置換されたインダノン類の製造方法およびその用途 | |
JPH0259816B2 (enrdf_load_stackoverflow) | ||
JPH0455427B2 (enrdf_load_stackoverflow) | ||
JP2704231B2 (ja) | 2―(4―フェニル―1―ピペラジニルアルキル)アミノ―5―エチニルピリミジン誘導体並びにその中間体及びその製造法 | |
JP2549950B2 (ja) | イミダゾ[1,2−a]ピリジン誘導体、その製造方法及びその中間体としてのα−ハロケトン誘導体 | |
JPS6339862A (ja) | ピリジルアミノフエノ−ル誘導体 | |
JPS6011704B2 (ja) | 5−フルオルウラシル誘導体の製造法 | |
JP2602783B2 (ja) | 4−ヒドロキシクマリン誘導体の製造方法 | |
JP4701185B2 (ja) | カンプトテシン誘導体の製造方法 | |
JPS6152133B2 (enrdf_load_stackoverflow) | ||
JPH0247470B2 (ja) | Indometashinjudotai | |
JP2518350B2 (ja) | ベンゾチアゾロン類の製造方法 | |
JPS5943469B2 (ja) | 光学活性トランス−ヘキサヒドロジベンゾピラノン類の製法 | |
JPH11302216A (ja) | ジアルコキシ置換インダノン誘導体の製造方法 | |
JPH0160022B2 (enrdf_load_stackoverflow) | ||
JPS59161373A (ja) | ジカルボン酸ジエステル及びその製造方法 | |
JPS61152665A (ja) | 六置換ベンゼン誘導体 | |
JPH06316556A (ja) | γ−フルオロスルホン誘導体およびその製造法 | |
JPH0449551B2 (enrdf_load_stackoverflow) | ||
JPH032139A (ja) | メガスチグマトリエノンの製法およびそれに使用し得る新規な化合物 | |
JPS627197B2 (enrdf_load_stackoverflow) | ||
JPH0150713B2 (enrdf_load_stackoverflow) | ||
JPH0143754B2 (enrdf_load_stackoverflow) | ||
HU202814B (en) | Process for producing acyl-resorcin derivatives as aintermediates for leukotriene antagonists |